The cost and cost trajectory of whole‐genome analysis guiding treatment of patients with advanced cancers

Abstract

WGA costs decreased over the studied time horizon, but expenditures needed to realize WGA remain significant. Future research exploring costs and benefits of WGA-guided cancer care are crucial to guide health policy.